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Abstract
Nearly all organisms exhibit circadian rhythms, physiological and behavioral
patterns with a period of approximately twenty-four hours. These twenty-four hour
rhythms are timed by an endogenous clock located in the suprachiasmatic nuclei (SCN)
of the hypothalamus. One of the most interesting features of the circadian timing system
is its ability to shift in response to light. This feature provides a mechanism for resetting
the clock in order to maintain synchrony with the environmentallight/dark cycle. During
the early morning, light induces a phase advance in the clock, compensating for what
appears to be an early onset of day. During the late night, light induces a phase delay in
the clock that allows compensation for what appears to be a lengthening of daylight.
During the subjective day, light has no effect on the clock since the presence of light
confirms what is expected during the daytime. Previous studies have shown a circadian
expression of brain-derived neurotrophic factor (BDNF), a substance known to enhance
synaptic transmission and regulate neural input in other brain regions, and have provided
supporting evidence for a potential role ofBDNF in regulating the SCN' s sensitivity to
photic input in vivo. In this study, BDNF's role in advancing the clock was investigated

in vitro through the use of K252a, a substance known to block the functional receptor for
BDNF. When glutamate, the substance released onto the SCN in response to light, was
applied in the early morning, large phase advances of about 3.25 hours were observed.
Application of K252a with glutamate was shown to block this response, whereas
application of K252a alone was shown to have no effect. These results are consistent
with previous experiments conducted in vivo and continue to support a role for BDNF in
regulating photic sensitivity in the SCN.
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Chapter 1
Background and Significance

Introduction and Rationale for Circadian Research
The 24 hour rotation of the earth on its axis results in an environmental stimulus
of cyclic light and dark cues that influences the behavior of nearly all forms of life,
including plants, animals, and even humans. In adapting to this cycle of stimuli, most
organisms display circadian rhythms, "endogenous oscillations with a period of
approximately 24 hours" (Rusak and Zucker, 1979). Although once considered a
metaphysical conception (Dunlap et ai, 2004), circadian rhythms are found in all
eukaryotic organisms as well as many prokaryotic organisms (Takahashi, 1993) and
influence various "changes in physiology and behavior, such as hormone secretion,
temperature, and the sleep-waking cycle" (Hannibal, 2002). The presence of circadian
rhythms allows for significant adaptation by synchronizing internal activities with
fluctuations in the external environment (Rusak and Zucker, 1979).
The history of circadian research dates back to the 4th century B.C. when
Androsthenes, a scribe of Alexander the Great, documented daily patterns in plant leaf
and flower petal movements, but these and other such cycles were for many years
dismissed as responses to environmental stimuli rather than patterns of endogenously
driven mechanisms (Dunlap et aI, 2004; Lamburg, 1994). Ultimately, the existence of
endogenously driven circadian rhythms was substantiated and met with widespread
acceptance by the 1950s, and the source of this circadian acti vity was identified as the
suprachiasmatic nuclei (SCN) (See section on the Suprachiasmatic Nucleus).

1

Today, there are currently three basic questions that neurobiologists seek to
answer through their investigations of the circadian system: 1.) how does the SeN
generate a circadian signal, 2.) how does light adjust this signal, and 3.) how does the
SeN use this signal to influence other areas of the brain? Aside from a scientific
advancement of knowledge, there are also a number of medical reasons for studying
circadian function. The activity of the SeN influences a variety of physiological
functions, and there are several disorders in humans that are related to circadian
rhythmicity that stand to be alleviated through circadian research.
The outputs of the SeN (See Figure 1) synapse primarily within the hypothalamus
with additional projections to the midline thalamus and the basal forebrain (Moore,
1996). Projections to the basal forebrain and midline thalamus influence higher order
functions of the brain through secondary projections (Moore, 1996) whereas secondary
projections from the hypothalamus give the SeN circadian influence over various
activities such as sleep-wake cycles, hormone concentration in the blood, heart rate,
blood pressure, body temperature, eating and drinking, and metabolism (Moore, 1996;
Refinetti, 2000). The SeN influences the activity of many parts of the body either
directly or indirectly, so it is clearly evident that disruption of the circadian system can
have a significant impact on the body's function.
A thorough understanding of the circadian system holds the potential for
alleviating a variety of medical conditions. Statistics have shown vatious correlations
between time of day and infant mortality immediately after birth, sudden death after
abdominal surgery, and adult suicides (Refinetti, 2000). Furthermore, individuals who
work in healthcare, law enforcement, or other fields that require night shifts or frequent
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Figure 1: Primary and secondary projections of the SCN and the functions regulated
by its output. (From Moore, 1996)

3

shift rotations are more likely to experience heart disease, sleep disorders, digestive
disorders, and mood disturbances (Lamburg, 1994), and individuals who frequently travel
across time zones will more often suffer from the sleep disruption, mood swings,
gastrointestinal distress, impaired concentration, decreased cognitive ability, and lack of
coordination associated wi th jet lag (Moore, 1996).
In addition to jet lag and work-shift syndrome, problems with adjustment of the
clock (See section on entrainment) may also cause delayed sleep phase syndrome (DSPS)
or advanced sleep phase syndrome (ASPS) . Individuals with these disorders have
difficulty going to sleep or awakening at traditional hours, either failing to fall asleep
until very late at night and only awakening naturally in the late morning or afternoon or
becoming sleepy during the evening and consequently awakening in the very early
morning (Refinetti, 2000; Moore, 1996). Individuals suffering from these disorders show
no alteration of normal sleep quality or duration if they are socially capable of altering
their schedules to accommodate such atypical times for sleep, but oftentimes work or
family obligations result in sleep deprivation among these patients (Refinetti, 2000).
Some blind patients may suffer from problems with light-regulated clock
adjustment (See section on entrainment) if their visual damage affects the neural afferents
to the SCN (Moore, 1996). At least one study has documented that some individuals may
be visually blind but still capable of photic clock adjustment while others may display
free-running melatonin rhythms that may become out of sync with the solar cycle
(Czeisler, 1995). Individuals who are totally blind and unable to photically regulate the
pacemaker repOlt sleep disturbances and insomnia during times in which the melatonin
rhythm is out of phase with the intended sleep period (Czeisler, 1995).

4

Aging is another problem that affects the circadian system. Decreased amplitude
of the circadian rhythm as well as changes in the clock's period are characteristic of
aging (Zhang et ai, 1996). Decreased amplitude has been associated with greater
fragmentation of sleep, less slow-wave sleep, decreased amplitude of the body
temperature rhythm, and a decrease in the amplitude of the cortisol and melatonin
rhythms (Moore, 1996). Decreased amplitude of the circadian rhythm is especially
pronounced in individuals with Alzheimer's disease and is most likely the result of a
decrease in the number of cells found in the SCN (Moore, 1996).
Circadian research may also benefit the medical field by improving the very
timing of medical therapy. Chronopharmacology refers to the practice of administering
drugs at times in which the drugs are known to be most effective and have the least side
effects (Refinetti, 2000). The symptoms of various diseases, including asthma, arthritis,
epilepsy, and hypertension, demonstrate circadian rhythmicity, and research has shown
that the pharmacodynamics and pharmacokinetics of many drugs also display circadian
rhythmicity (Refinetti, 2000).
Continued research on the SCN at the cellular and molecular level will be
instrumental for gaining a comprehensive understanding of how the clock works,
including how it is reset and how it influences behavior and physiology. Likewise,
treatment for medical disorders will require a more solid understanding of how the SCN
works at the molecular level, helping to not only further explain the causes of certain
medical conditions but to improve the efficacy of our treatments through a better
understanding of the rhythmic variations in our physiology.

5

The Suprachiasmatic Nucleus
With the acknowledgement of a circadian clock came the search to find it.
Ultimately, researchers were able to conclude that the internal clock activity of mammals
rests within the suprachiasmatic nucleus (SeN). There is substantial evidence of the
seN's role in circadian rhythmicity, including experiments involving ablation of neurons
in the SeN and subsequent loss of circadian rhythmicity; persistence of circadian
rhythmicity of neurons in the SeN after isolation from the rest of the brain in vivo or in

vitro; and adoption of donor circadian periodicity in subjects receiving transplantation of
fetal SeN tissue after loss of their own rhythmicity due to SeN ablation (Moore, 1996).
The SeN are a pair of small, bilateral structures located in the anterior
hypothalamus, ventrolateral to the base of the third ventricle and just dorsal to the optic
chiasm . It is estimated that there are about 8000 neurons in each SeN (van den Pol,
1991), and SeN neurons are among the smallest neurons anywhere in the brain (van den
Pol, 1991; Rusak and Zucker, 1979). The SeN are sensitive to various stimuli and can
self-regulate its sensitivity to various stimuli to achieve the desired synchrony with
environmental and physiological cues (Gillette and Mitchell, 2002).
Each SeN is composed of two subdivisions: core and shell (Moore et ai, 2002).
In rats, the shell contains about 57% of the total neurons in the SeN, and neurons in the
core comprise the remaining 43% (Moore et ai, 2002). Innervation of the SeN from the
retinohypothalamic tract (RRT) terminates predominately in the core (Moore et aI, 2002)
(See Figure 2). A projection from the intergeniculate leaflet (lGL) via the
geniculohypothalamic tract (GRT) and a serotonin projection from the midbrain raphe
nuclei also terminate in the core of the SeN (Moore et aI, 2002). The shell receives
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Figure 2: Afferents to the core and shell of the SeN. (From Dunlap et aI, 2004)
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unnecessary for photic entrainment suggests the existence of additional photoreceptors
(Ruby et ai, 2002). Melanopsin has been suggested as the most likely photopigment used
for entrainment of the circadian pacemaker, but recent experiments with mice have used
knockout genes to show that melanopsin is not necessary for entrainment (Ruby et ai,
2002). However, phase and period responses were reduced in these knockout mice, so
while not essential, melanopsin does appear to playa significant role in contributing
photic information to the circadian pacemaker (Ruby et ai, 2002).

The Circadian Rhythm and Entrainment
Subjects maintained in an environment with no external timing cues demonstrate
a pattern of circadian activity that approximates 24 hours (Moore, 1996). This means that
the circadian clock persists in a free-running state, a state in which an endogenous rhythm
with inherent periodicity persists without environmental cues. This rhythm can be
visualized based on the activity of the subject, such as wheel running in mice for
example, by plotting this activity over a twenty-four hour period. Cells of the SCN
continue to fire in a circadian pattern for at least three days in vitro, so electrical
recordings can also be used to visualize the circadian rhythm by plotting the frequency of
action potential firing in SCN cells over time. In this case, such a plot (See Figure 3) will
demonstrate the classic sinusoidal oscillation of circadian rhythmicity with peak activity
near mid-subjective day and diminished activity during the subjective night (Gillette,
1991).
Because circadian pacemakers generate their rhythms endogenously, the SCN
must be capable of resetting itself regularly in order to compensate for variations in the
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Figure 3: Schematic of the circadian rhythm depicting the firing rate of neurons in the
SeN of an entrained mouse housed in alternating 12 hour periods of light and
darkness (12:12 LD). The lights-on period occurs at zeitgeber time 0 (ZT 0;
zeitgeber means "time giver;" ZT begins at lights-on in the entrained cycle and
repeats after 24 hours) and lights off occurring at ZT 12. The dark horizontal bar
between ZT 12 and ZT 24 signifies the lights-off period (i.e. the subjective night).
Peak firing activity occurs near midday (ZT 6) with firing activity lessened during
the subjecti ve night.
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amount of daylight throughout the year, discrepancies between the period of the
endogenous clock and the period of the earth's rotation, or differences in environmental
cues resulting from travel across time zones. This process of adjusting the clock is called
entrainment and is achieved primarily through the environmental stimulus of light
(Moore, 1996). This resetting of the clock in response to a stimulus such as light can be
visualized by plotting the SCN neuronal firing rate in vitro over time (See Figure 4).
In order to relay a clock-adjusting light stimulus to the brain, the RHT releases the
neurotransmitter glutamate (Gillette and Mitchell, 2002). In vivo expel;ments with light
pulses and in vitro experiments with glutamate application have both demonstrated
biphasic responses in the circadian rhythm when given during the subjective night
(Gillette and Mitchell, 2002). When given during the early night, a delay in behavioral
activity or peak neuronal firing activity in the SCN is observed, whereas an advance of
activity is observed when the light/glutamate stimulus is given during the late night
(Gillette and Mitchell, 2002). Intuitively, these observations make sense because a Jight
stimulus during the early night would indicate a delay of sunset, and a light stimulus just
before the lights-on period would be indicative of an early onset of daylight.
The full mechanism through which light acts on the SCN in order to cause a phase
shift is unknown, but a number of pathways are thought to be involved. In response to
light, the retinal afferents to the SCN release glutamate, which acts on SCN neurons by
activating N-methyl-D-aspartate (NMDA) receptors (Ding et aI, 1994). The rise in
intracellular Ca2+ concentration through activated NMDA receptors causes stimulation of
nitric oxide synthase (NOS) (Ding et aI, 1994), which releases nitric oxide (NO) when it
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Figure 4: Schematic of the circadian rhythm depicting the advance in peak firing rate of
neurons in the SCN in response to an early morning glutamate stimulus
(glutamate is released onto the SCN in response to light). The dashed curve
represents the normal circadian rhythm of a mouse housed in12:12 LD, whereas
the solid curve represents the phase-advanced rhythm in response to a glutamate
stimulus. The horizontal dark bar represents "lights-off' in the colony, and the
vertical, dashed line represents time of peak firing activity under control
conditions. The vertical, shaded bar represents time of light stimulus.
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converts L-arginine to L-citrulline. The downstream events in this signal transduction
pathway are less clear, but it is believed that production of NO induces phosphorylation
2

of the Ca +/cAMP response element binding protein (CREB) (Ding et aI, 1997) and
2

activation of Ca +/cAMP response element (CRE)-mediated transcription (Obrietan et ai,
1999).
Experiments have revealed a circadian oscillation in CRE-mediated gene
expression in dark-adapted animals and have shown CRE-mediated transcription
triggered in response to photic stimulation during the subjective night (Obrietan et aI,
1999). This pattern of CREB activation correlates with the induction of many immediate
early genes that have suspected involvement in phase shifting, and many of these genes
have activity-sensitive CRE promoter elements that are regulated by CREB (Obrietan et
aI, 1999; Deisseroth et aI, 2003). Taken together, there is increasing evidence to support
the idea that light activates gene expression through the CREB/CRE-transcriptional
pathway in order to phase shift the clock (Obrietan et aI, 1999; Deisseroth et aI, 2003).
While the specific pathway leading to CREB phosphorylation is not known, the
differing effects of light/glutamate stimuli between early and late night suggests that
different pathways may be involved. The increase in Ca2+ concentration could activate
Ca2 +/calmodulin-dependent protein kinase (CaM kinase), which has been shown to playa
role in P-CREB formation in hippocampal neurons (Ding et aI, 1997; Deisseroth et aI,
2003). A recent experiment showed that disruption of the p42/44 mitogen-activated
protein kinase (MAPK) pathway blocks clock entrainment, and this pathway was
reported to function downstream of the CaM kinase pathway (Butcher et aI, 2002). The
production of NO from NOS activation could also lead to activation of guanylate cyclase
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(GC), production of cyclic GMP (cGMP), and subsequent activation of protein kinase G
(PKG) (Ding et ai, 1997). Because light/glutamate-induced phase advances have been
blocked by a specific PKG inhibitor (Weber et ai, 1995), this NO/GC/cGMPIPKG
pathway is likely activated during the late night. However, other pathways may still be
activated during this timeframe, particularly in light of the fact that the amplitude of the
light/glutamate-induced phase shift is smaller than that of the phase shift induced by
cGMPIPKG alone (Gillette and Mitchell, 2003).
During the early night, experiments have shown that blocking the cGMPIPKG
pathway has no effect on glutamate-induced phase delays, so the NO/GC/cGMPIPKG
pathway involved in glutamate-induced phase advances is not involved in glutamateinduced phase delays. (Ding et ai, 1998). Additional experiments revealed glutamate-like
phase delays through activation of ryanodine receptors (RyR) whereas inhibition of RyRs
blocked glutamate-induced phase delays (Ding et aI, 1998). The specific pathway
involved between glutamate and RyRs is unclear, but nitric oxide as an intermediary
could stimulate the ADP ribosyl cyclase pathway and lead to activation of RyRs through
nitric oxide-mediated polynitrosylation (Ding et ai, 1998).
Regardless of the specific pathways involved, the ability of the SCN to gate its
sensitivity to light is an instrumental feature of the circadian system. Identification of the
mechanism by which the SCN gates its sensitivity to photic input is an important step
toward understanding the process of entrainment. Recently, attention has been directed
toward a specific growth factor as a potential candidate for regulating the SCN's
sensitivity to light, and this substance will be the central focus of my research in this
project.

14

Brain-Derived Neurotrophic Factor
The mechanism through which the SCN gates its sensitivity to photic input is of
central importance to understanding circadian function. Recently, a regulatory role in

pacemaker sensitivity to light has been suggested for brain-derived neurotrophic factor
(BDNF), a secretory protein that belongs to the neurotrophin family and preferentially
binds the tyrosine kinase B receptor (TrkB) (Lu 2003). Part of the evidence for this
hypothesis has come from the realization that BDNF plays critical roles in synaptic
transmission and plasticity in other areas of the brain (See Lu, 2003 for review). These
roles include facilitation of long-term potentiation in the hippocampus and visual cortex,
modulation of dendritic and axonal growth in the brain, and regulation of synaptic
transmission in glutamatergic, and GABAergic synapses, all of which support a role for
BDNF in modulation of synaptic structures and function (Lu, 2003).
Expression of BDNF and its cognate receptor, TrkB, was recently identified in the
SCN of adult rats (Liang et ai, 1998b), and both BDNF and BDNF mRNA levels were
recently found to oscillate in a circadian pattern, increasing during the early subjective
night, peaking near the mid subjective night, and tapering off to minimal levels
throughout the subjective day (Liang et aI, 1998a). These findings support the idea that
BDNF could gate the response of the SCN to photic input since its concentration is
maximal during the subjective night when light/glutamate is capable of producing a shift
in the circadian curve but is minimal during the subjective day when stimulation by
light/glutamate has no effect (Liang et ai, 1998a).
Recently, BDNF was shown to stimulate nuclear CREB phosphorylation in the
2

hippocampus through stimulation of Ca +/calmodulin-dependent protein kinase 2
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(CaMKII), subsequent downstream activation of the p38 subfamily of mitogen-activated
protein kinases (MAPK), and then downstream activation of MAPK-activated protein
kinase 2 (MAPKAPK-2) (Blanquet et aI, 2003). Because CREB phosphorylation is
involved in phase-shifting the circadian clock, BDNF's role in CREB phosphorylation in
the hippocampus further supports a possible role for BDNF in gating photic input in the
SCN.
Another study has shown that BDNF can rapidly enhance synaptic transmission
by promoting phosphorylation and dephosphorylation of NMDA receptor subunits and
thereby increasing or decreasing their likelihood of being open (Lin et aI, 1999). As
described above, NMDA receptors open in response to glutamate activation in the SCN
and allow influx of Ca2+. Therefore, this activity of BDNF could have a significant
impact on the SCN's response to glutamate and provide another potential mechanism for
gating photic sensitivity.
In order to better substantiate a role for BDNF in photic gating, a series of
experiments were performed in vivo to determine if K252a, a substance known to block
tyrosine kinase receptors, could eliminate light-induced phase shifts of the wheel running
activity in rats (Liang et aI, 2000). These experiments utilized an implanted cannula to
allow infusion of K252a into the SCN. Multiple trials were conducted in which rats were
exposed to thirty minute light pulses at either zeitgeber time 14 (ZT 14; zeitgeber means
"time giver" and zeitgeber time begins at ZT 0 with the onset of the lights-on period in
the colony and continues for twenty four hours before repeating) or ZT 22, times known
to induce maximal phase delays and phase advances respectively, in the presence and
absence of K252a. The results of these trials were compared with the results of trials
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without light stimulation in which K252a was injected at ZT 14 and ZT 22 to ensure that
the blocker itself did not cause any unintended effects. These trials showed that infusion
of K252a blocks light-induced phase advances and phase delays. Another experiment
was conducted in which the inability of light to induce a phase shift during the subjective
day was confirmed through a light stimulus at ZT 6. Then, infusion of BDNF was given
prior to a light pulse at ZT 6. BDNF administration was shown to enable large lightinduced phase advances during the subjective day.
The results of this study led the researchers to conclude that BDNF modulates the
receptivity of the circadian pacemaker to photic input. This was based on the
observations that blocking the functional BDNF receptor prevented light-induced phase
shifts, while application of BDNF enabled light to induce phase shifts when it ordinarily
would not. However, this series of experiments were conducted in vivo, and certain
difficulties can arise in controlling for all variables in experiments of this type.
Therefore, I have set out to replicate these experiments in vitro in order to isolate the

SeN and its surrounding region in a better controlled environment and provide a more
definitive analysis of the role of BDNF in photic entrainment. The focus of this study
will be limited to an analysis of the role of BDNF in light/glutamate-induced phase
advances.

17

Data Acquisition and Analysis
Data collection began at ZT a of day two, approximately two hours after drug
treatments commenced (see below). During these experiments, a microelectrode filled
with 3M saline solution was used to record from individual neurons for five-minute
periods, and the activity of four to seven neurons per hour was recorded. Data were
collected and analyzed with a DataWave system (Longmont, CO). Later, these data were
analyzed to visibly identify and remove background noise picked up by the
microelectrode. Then, the clean recordings were used to detennine the firing rates of the
individual neurons. Two hour running averages were then calculated with standard error
and plotted on a graph in order to identify the time of peak firing activity. This peak time
was visually estimated to the nearest quarter hour based on the symmetry of the curve.
This information was then used to identify phase-shifts of the circadian curve and thereby
assess the effects of the experimental treatments.

Experimental Protocol
Control Experiments:
Five trials of experiments were initially conducted to establish the normal pattern
of circadian activity in the SCN of mice housed under 12: 12 LD conditions. During these
trials, extracellular recording of individual neurons in the SCN began at ZT O. Fiveminute recordings were obtained from four to seven cells each hour until ZT 10. While
this timeframe did not allow for monitoring the entire twenty-four hour rhythm, this ten
hour period allowed me to accurately determine the time of peak firing activity of
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neurons and allowed for accurate visualization of any phase shifting of peak activity
resulting from experimental treatments.

Glutamate Treatment:
Four trials of experiments were conducted using exogenous glutamate application
at ZT 22. To apply the glutamate, the perfusion was stopped, and the normal medium
was removed from the dish and replaced with a 1mM solution of glutamate dissolved in
EBSS. After ten minutes, this solution was removed, and normal perfusion of EBSS was
resumed.

K252a Treatment:
Four trials of experiments were conducted using exogenous application of K252a,
a substance known to block the TrkB receptor, the functional receptor for BDNF. At five
minutes before ZT 22, the perfusion was stopped, and the normal medium was removed
from the dish. The dish was then filled with a IIlM solution of K252a dissolved in
EBSS. K252a was added five minutes before ZT 22 so that all receptors for BDNF
would be blocked at the time of glutamate application (ZT 22). Although glutamate was
not used in this series of control experiments, K252a application began five minutes early
in order to remain consistent with subsequent experimental trials. After twenty minutes,
this solution was removed and normal perfusion of EBSS was resumed. K252a was left
in the dish five minutes beyond the time of intended removal of glutamate in order to
protect against the effects of any lingering glutamate in the dish that could have
potentially induced a phase-shift once receptors for BDNF were no longer blocked.
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Again, K252a application was prolonged in this series of control experiments in order to
remain consistent with K252a application in the subsequent experimental trials.

Glutamate + K252a Treatment:
Four trials of experiments were conducted with application of K252a and
glutamate. At five minutes before ZT 22, the perfusion was stopped, and the normal
medium in the dish was replaced with a l/lM solution of K252a dissolved in EBSS. At
ZT 22, this solution was removed from the dish and replaced with a l/lM solution of
K252a dissolved in a 1mM solution of glutamate and EBSS. After ten minutes, this
solution was removed and once again replaced with a l/lM solution of K252a dissolved
in EBSS. After five minutes, this solution was again removed, and normal perfusion of
EBSS was resumed.

DMSO Trials:
As purchased, K252a was dissolved in DMSO. Because DMSO was also present
in solutions containing this blocker, two experiments were conducted with a 1mM
solution of DMSO dissolved in EBSS. At five minutes before ZT 22, perfusion was
stopped, and the DMSO solution replaced the normal EBSS in the dish. After twenty
minutes, this solution was removed from the dish, and normal perfusion of EBSS was
resumed.

21

Statistical Analysis
The statistical significance of the times of peak neuronal firing activity were
assessed using Student's t-test, and the level of significance was set at P < 0.05.
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Chapter 3
Results
Experiments (n = 5) conducted with untreated brain slices revealed a circadian
curve of neural firing activity peaking near midday. The mean time of peak activity for
untreated slices was ZT 5.95+/-0.47 hours (See Figure 5). This is consistent with
previous experiments for this lab (Prosser, 2003). When slices were treated with the
1mM glutamate solution at ZT 22, the mean time of peak firing activity in the SCN was
ZT 2.44+/-0.18 (See Figure 6). This translates to a statistically significant phase advance
of approximately 3.5 hours (p < 0.05). This phase shift is similar to that shown in
previous in vitro experiments using SCN brain slices from rats (Ding et ai, 1997).
Experiments conducted with brain slices treated with 1JlM K252a solution at ZT 22
revealed no statistically significant phase shift of the circadian curve. Peak firing activity
was still observed near midday with a mean peak firing time of ZT 5.94+/-0.07 (See
Figure 7). Experiments conducted with brain slices treated with both glutamate and
K252a revealed a mean peak firing time of ZT 5.88+/-0.36 (See Figure 8). This shift is
not statistically different from controls, but it is statistically different from the time of
peak activity seen after glutamate application (See Figure 9). Experiments conducted
with brain slices treated with DMSO also demonstrated a midday peak of neural firing
activity (Figure not shown). The mean peak firing rate was ZT 6.13+/-0.18, and this is
not statistically different from controls.
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Figure 5: In vitro circadian rhythm of neuronal activity. Dots represent two-hour
running averages +/- SEM, and the dark horizontal bars between ZT 12 and ZT 24
represent the "lights off' period in the mouse's entrained cycle. Recordings
revealed a mean time of peak activity for untreated slices of ZT 5.95+/-0.47
hours .
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Figure 6: Circadian rhythm in neuronal activity recorded after ten minute glutamate
treatment at ZT 22. Shown are two-hour running averages +/- SEM with peak
firing activity occurring at ZT 2.44+/-0.18. The horizontal bars represent "lightsoff' in the colony, and the vertical bar represents time of drug treatment. The
dashed vertical line represents time of peak activity in control experiments.
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Figure 7: Two-hour running averages of neuronal firing activity in the SeN in response
to K252a treatment at ZT 22. Peak activity occurs at ZT 5.94+1-0.07. Horizontal
bars represent "lights-off' in the colony, and the vertical bar represents time of
drug treatment. The dashed vertical line represents time of peak firing activity in
control experiments.
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Figure 8: Two-hour running averages of neuronal firing activity in the SeN in response
to Glutamate + K252a treatment at ZT 22. Peak activity occurs at ZT 5.88+/0.36. Horizontal bars represent "lights-off' in the colony, and the vertical bar
represents time of drug treatment. The dashed vertical line represents time of
peak firing activity in control experiments.
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Glutamate phase advances blocked by
TrkB antagonist K252a in vitro
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Figure 9: Mean phase advances in response to specified drug treatments at ZT 22.
Glutamate induced a statistically significant average phase advance of 3.5 hours.
Slices treated with glutamate + K252a showed no statistically significant phase
shift relative to controls, but these experiments did reveal a statistically significant
phase shift relative to experiments conducted with glutamate treatments.
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Chapter 4
Discussion and Future Directions

The results of this experiment are consistent with the hypothesis that brainderived neurotrophic factor (BDNF) is involved in glutamate-induced circadian phase
advances. The results of this experiment also provide the first in vitro confirmation of
previous findings from in vivo experiments. Given that the role of BDNF in circadian
phase shifting determined in this experiment is consistent with the results of in vivo
experiments on advance shifting, one can reasonably anticipate that further in vitro
experiments will continue to show that blocking the trkB receptor with K252a will block
glutamate-induced phase delays as well. However, a number of additional experiments
are necessary to support the conclusion that BDNF binding is a necessary event for all
glutamate-induced phase shifting to occur.
First, the experiments done in this study need to be repeated at CT 14. Data from
these experiments are necessary to support BDNF's role in glutamate-induced phase
delays. Results from previous experiments in vivo have supported a role for BDNF in
glutamate-induced phase delays, and replication of the experiments in this study at ZT 14
are expected to further support this role in vitro.
Second, we need to determine the effects of daytime glutamate application in the
presence of BDNF in vitro. In previous experiments, application of BDNF enabled phase
shifting to occur in response to a light stimulus at ZT 6 in vivo. Therefore, further studies
must be conducted with daytime application of BDNF at ZT 6 in order to determine if the
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presence of this growth factor during the subjective day can enable a phase shift to occur
with daytime application of glutamate in vitro.
Third, the inhibitory effects of K252a need to be replicated with a more specific
receptor tyrosine kinase inhibitor, such as AG879. Data from these experiments will
further substantiate the conclusion that K252a is blocking the glutamate-induced phase
shifts by blocking the TrkB receptor rather than inhibiting the activity of other tyrosine
kinases.
Should these experiments confirm a role for BDNF/TrkB receptor activation in
photic phase shifts, it will be important to determine exactly what BDNF is doing to
achieve this effect. Data from other systems has shown that BDNF activates intracellular
processes such as phosphorylation of NMDA receptor subunits and activation of CREB,
both of which could potentially provide mechanisms for gating photic sensitivity, so
further experiments will be necessary to determine if these and other processes occur in
cells of the SCN.
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